Previous Article | Next Article 
Journal of Clinical Microbiology, September 2000, p. 3448-3449, Vol. 38, No. 9
0095-1137/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Seroepidemiological Survey of Infection by Feline
Leukemia Virus and Immunodeficiency Virus in Madrid and Correlation
with Some Clinical Aspects
Alvaro
Arjona,1
Elena
Escolar,2
Iria
Soto,1
Nuria
Barquero,1
Daniel
Martin,1 and
Esperanza
Gomez-Lucia1,*
Departamento Patología Animal I
(Sanidad Animal)1 and Departamento
Patología Animal II (Medicina Animal),2
Facultad de Veterinaria, Universidad Complutense, 28040 Madrid, Spain
Received 2 March 2000/Returned for modification 20 April
2000/Accepted 12 June 2000
 |
ABSTRACT |
A study of 180 healthy cats found that 15.6% were feline leukemia
virus (FeLV) positive, 8.3% were feline immunodeficiency virus (FIV)
positive, and 1.1% were FIV and FeLV positive, which corresponded to
30.4, 13.8, and 2.6, of 115 cats with FIV- and FeLV-related symptoms,
respectively. Differences were seen in the sexes and ages of the
populations studied. Anemia, leukopenia, and lymphopenia were the most
frequent hematological abnormalities in infected cats.
 |
TEXT |
Two of the three members of the
family Retroviridae described in cats are pathogenic: feline
leukemia virus (FeLV) and feline immunodeficiency virus (FIV). Both
retroviruses have a worldwide distribution. FeLV is transmitted
primarily by saliva and respiratory secretions, but it is also secreted
by urine, feces, tears, and milk (3, 8). Contagion occurs
through the sharing of food and drink containers and by behavior such
as grooming of one another. FIV is very similar to human
immunodeficiency virus type 1 (HIV-1), to the extent that it has been
proposed as the best animal model with which to study the pathogenesis
of HIV-1 and therapy for humans infected with the virus (3).
FIV is shed mainly in the saliva (8) and is transmitted
mostly through bite wounds (4, 8, 19), but it is also
transmitted in utero or through colostrum and milk (8). FIV
induces a progressive immune dysfunction, which develops for months or
even years.
The aim of the present work was to estimate the percentage of healthy
and symptomatic cats in Madrid infected with the feline retroviruses
(FeLV and FIV) as representative of the situation in urban areas in
Spain. Some epidemiological parameters of the infected cats such as
sex, age, and origin were also studied. Hematological values and renal
function were compared between healthy and sick cats.
Cats from the Madrid metropolitan area were sampled between January and
November 1999. Group H included 180 healthy animals brought to a
veterinary practice for vaccination or a routine checkup. Group S
included 115 animals that showed signs such as anorexia, depression,
fever, lymphomegaly, stomatitis, rhinotracheitis, generalized skin
infections, or tumors which could be related to infection with feline
retroviruses. Data collected from the animals included age, sex,
origin, lifestyle, and vaccination and clinical histories. Blood was
collected from the animals to determine whether they were infected with
FIV and/or FeLV by using a commercial kit (Snap Combo Plus R; Idexx,
Inc., Westbrook, Maine). According to the literature, the sensitivity
and specificity of this type of enzyme-linked immunosorbent assay range
between 93 and 100% (2, 5, 9, 13, 17).
Among the 180 cats in group H, 15.6% were found to be FeLV positive,
8.3% were FIV positive, and 1.1% were positive for both viruses. With
respect to the 115 animals in group S, 30.4% were FeLV positive,
13.9% were FIV positive, and 2.6% were positive for both viruses.
Among the cats in group H, the prevalence of FeLV agrees with data from
other studies: 18% in Italy (1) and 13.4% in Germany
(6). In the case of the percentage of cats infected with
FIV, results were also similar to those of previous studies in Western
Europe: 11% in France (4) and 6% in the United Kingdom
(11). Other studies obtained different prevalences of
infected cats: 2% FeLV-positive cats in Sydney, Australia
(15), 1.2% FeLV-positive cats in Norway (18),
0.7% FIV-positive cats in Switzerland (14), and 44%
FIV-positive cats in Japan (12). These differences are
probably related to sociocultural circumstances, which determine the
lifestyles and origins of the domestic cats and possibilities for
interactions between infected and noninfected cats. As might be
expected, the percentage of cats infected with FeLV, FIV, and both
viruses was almost double in cats in group S compared with that in cats
in group H. It is worth mentioning that the clinical signs are very nonspecific, and a high percentage of animals with clinical signs suggestive of infection with FIV or by FeLV were negative for both retroviruses.
To study the influence of age, cats were classified in three
categories: young (<3 years old), mature (3 to 8 years old), and
senior (>8 years old). Among the cats in group H, 70% of the FeLV-positive animals were young, 20% were mature, and 10% were senior. Among the FIV-positive cats in group H, the proportions were
20, 60, and 20%, respectively. Among the FeLV-positive cats in group
S, 50.1% were young, 42.8% were mature, and 7.1% were senior cats.
Among the FIV-positive cats in group S, the age distributions were
33.4, 55.5, and 11.1%, respectively. The average older age of
FIV-positive cats in group H probably reflects the fact that FIV is
more easily transmissible by bites. Besides transmission from queens,
the fact that FeLV-positive animals were younger than FIV-positive
animals may also indicate that animals infected with FeLV die at a
younger age and fewer infected animals reach an older age.
When classified by sex, the percentages of FeLV-positive or
FIV-positive males in group H (63.2 and 83.3%, of the 103 animals whose sexes were known, respectively) were significantly higher than
those for females (P < 0.05). On the other hand, the
proportions of FeLV-positive and FIV-positive males among the 94 cats
in group S were only 41.4 and 50%, respectively. These differences
were significant (P < 0.05). These data seem to
indicate that sex may somehow influence the development of signs
related to FeLV or FIV infection. Other investigators (10)
have also detected sex-related differences in the rate of FIV
positivity among cats, especially in the sense that estradiol may
protect peripheral lymphocytes from apoptosis after stimulation.
The number of red blood cells (RBCs), the number of leukocytes (WBCs),
and the leukocyte formula were determined for 27 FeLV-positive, 9 FIV-positive and 43 FIV- and FeLV-negative cats, including cats in both
groups H and S. The intervals considered normal were 5.5 million to 10 million RBCs/µl, 5,500 to 19,500 WBCs/µl, 35 to 75% neutrophils,
and 20 to 55% lymphocytes. Fifty percent of the FeLV-positive cats,
44% of the FIV-positive cats, but only 14% of the FIV- and
FeLV-negative cats had anemia. Thus, FeLV and FIV infections seem to be
related to anemia, even though there was only a statistical association
with FeLV infection (P < 0.05). Concerning the number
of WBCs, 46.2% of the FeLV-positive cats had leukopenia, while 30.8%
had leukocytosis. There was a statistical association between
leukopenia and infection with FeLV (P < 0.05). This
agrees with the fact that the most frequent clinical manifestation in
cats infected with FeLV is the development of secondary infections due
to severe immunodeficiency (7). In the case of cats infected with FIV, there was no predominant alteration, which may indicate that
the animals studied were in different clinical stages of the disease,
each one characterized by a specific alteration. The most frequent
variations were neutropenia (33.3% of FeLV-positive cats) and
lymphopenia (37.5% of FIV-positive cats).
Some investigators have suggested that infection with feline
retroviruses may induce renal lesions due to the deposit of immune complexes in renal tissues (12, 16). Urea and creatinine
levels were determined in 213 plasma samples of cats in groups H and S;
48 of them were FeLV positive and 25 were FIV positive. High urea
levels (>20 to 50 mg of urea/dl) were seen in 45.8% of the FeLV-positive cats, 62.5% of the FIV-positive cats, and 51% of the
FIV- and FeLV-negative cats. The proportions of animals in these three
groups with high creatinine levels (>1 to 2 mg of creatinine/dl) were
9.1, 16.7, and 13.2%, respectively. Thus, in the present study, no
significant difference was seen in the values of urea and creatinine
(suggestive of renal failure) between noninfected and infected cats.
However, the absence of renal lesions may be confirmed only by
histological techniques.
From the results of this study, we may conclude that an important
percentage of cats are infected with FIV and FeLV and have no clinical
signs. Accordingly, the everyday veterinary practice should aim to
detect these retroviruses in all cats that come to the practice for the
first time in order to control the infection. In addition, FIV and FeLV
detection is also necessary for sick cats, as the clinical signs are
varied and nonspecific, so that appropriate measures can be taken,
especially avoidance of free roaming.
 |
ACKNOWLEDGMENTS |
We thank the veterinary practitioners who have participated in this
study. In this sense, we are especially grateful to Gustavo Sanchez
Visconti and the personnel of the Laboratorio de Analisis Veterinarios,
as well as the staff of the Hospital Clinico Veterinario, for their
kind collaboration. The assistance of Jose Antonio Ruiz-Santa-Quiteria in the epidemiological study and David Bruhn for his editorial work are
gratefully acknowledged.
This work was supported by grants from the Spanish government
(CAM-08.2/0011/98/98 and DGES-PM98-0077/98).
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Dpto.
Patología Animal I (Sanidad Animal), Facultad de Veterinaria,
Universidad Complutense, 28040 Madrid, Spain. Phone: 34-91-394-3718. Fax: 34-91-394-3908. E-mail:
duato{at}eucmax.sim.ucm.es.
 |
REFERENCES |
| 1.
|
Bandecchi, P.,
D. Matteucci,
F. Baldinotti,
G. Guidi,
F. Abramo,
F. Tozzini, and M. Bendinelli.
1992.
Prevalence of feline immunodeficiency virus and other retroviral infections in sick cats in Italy.
Vet. Immunol. Immunopathol.
31:337-345[CrossRef][Medline].
|
| 2.
|
Barr, M. C.,
M. B. Pough,
R. H. Jacobson, and F. W. Scott.
1991.
Comparison and interpretation of diagnostic tests for feline immunodeficiency virus infection.
J. Am. Vet. Med. Assoc.
199:1377-1381[Medline].
|
| 3.
|
Bendinelli, M.,
M. Pistello,
S. Lombardi,
A. Poli,
C. Garzelli,
D. Matteucci,
L. Ceccherini-Nelli,
G. Malvaldi, and F. Tozzini.
1995.
Feline immunodeficiency virus: an interesting model for AIDS studies and an important cat pathogen.
Clin. Microbiol. Rev.
8:87-112[Abstract].
|
| 4.
|
Courchamp, F., and D. Pointer.
1994.
Feline immunodeficiency virus: an epidemiological review.
C. R. Acad. Sci. Ser. III
317:1123-1134[Medline].
|
| 5.
|
del Fierro, G. M.,
P. Bundesen,
S. Martin,
S. Jones,
S. Beetson, and W. F. Robinson.
1995.
Evaluation of an autologous red cell agglutination test, VetRED FIV, for the presence of FIV antibody in cats.
Vet. Immunol. Immunopathol.
46:93-101[CrossRef][Medline].
|
| 6.
|
Fuchs, A.,
L. Binzel, and M. Lonsdorfer.
1994.
Epidemiology of FeLV and FIV infection in the Federal Republic of Germany.
Tierarztl. Prax.
22:273-277[Medline].
|
| 7.
|
Hardy, W. D., Jr., and M. Essex.
1986.
FeLV-induced feline acquired immune deficiency syndrome (FAIDS). A model for human AIDS.
Prog. Allergy
37:353-376[Medline].
|
| 8.
|
Hartmann, K.
1998.
Feline immunodeficiency virus infection: an overview.
Vet. J.
155:123-137[CrossRef][Medline].
|
| 9.
|
Hawks, D. M.,
A. M. Legendre, and B. W. Rohrbach.
1991.
Comparison of four test kits for feline leukemia virus antigen.
J. Am. Vet. Med. Assoc.
199:1373-1376[Medline].
|
| 10.
|
Hofmann-Lehmann, R.,
E. Holznagel, and H. Lutz.
1998.
Female cats have lower rates of apoptosis in peripheral blood lymphocytes than male cats: correlation with estradiol-17beta, but not with progesterone blood levels.
Vet. Immunol. Immunopathol.
65:151-160[CrossRef][Medline].
|
| 11.
|
Hosie, M. J.,
C. Robertson, and O. Jarrett.
1989.
Prevalence of feline leukaemia virus and antibodies to feline immunodeficiency virus in cats in the United Kingdom.
Vet. Rec.
125:293-297[Abstract].
|
| 12.
|
Ishida, T.,
T. Washizu,
K. Toriyabe,
S. Motoyoshi,
I. Tomoda, and N. C. Pedersen.
1989.
Feline immunodeficiency virus infection in cats of Japan.
J. Am. Vet. Med. Assoc.
194:221-225[Medline].
|
| 13.
|
Jacobson, R. H., and N. A. Lopez.
1991.
Comparative study of diagnostic testing for feline leukemia virus infection.
J. Am. Vet. Med. Assoc.
199:1389-1391[Medline].
|
| 14.
|
Lutz, H.,
R. Lehmann,
G. Winkler,
B. Kottwitz,
A. Dittmer,
C. Wolfensberger, and P. Arnold.
1990.
Feline immunodeficiency virus in Switzerland: clinical aspects and epidemiology in comparison with feline leukemia virus and coronaviruses.
Schweiz Arch. Tierheilkd.
132:217-225[Medline].
|
| 15.
|
Malik, R.,
K. Kendall,
J. Cridland,
S. Coulston,
A. J. Stuart,
D. Snow, and D. N. Love.
1997.
Prevalences of feline leukaemia virus and feline immunodeficiency virus infections in cats in Sydney.
Aust. Vet. J.
75:323-327[Medline].
|
| 16.
|
Poli, A.,
F. Abramo,
D. Matteucci,
F. Baldinotti,
M. Pistello,
S. Lombardi,
P. Barsotti, and M. Bendinelli.
1995.
Renal involvement in feline immunodeficiency virus infection: p24 antigen detection, virus isolation and PCR analysis.
Vet. Immunol. Immunopathol.
6:13-20.
|
| 17.
|
Swango, L. J.
1991.
Evaluation of feline leukemia virus diagnostic tests available for in-office use by veterinarians.
J. Am. Vet. Med. Assoc.
199:1386-1389[Medline].
|
| 18.
|
Ueland, K., and H. Lutz.
1992.
Prevalence of feline leukemia virus and antibodies to feline immunodeficiency virus in cats in Norway.
Zentbl. Vet. Med. B
39:53-58.
|
| 19.
|
Yamamoto, J. K.,
H. Hansen,
E. W. Ho,
T. Y. Morishita,
T. Okuda,
T. R. Sawa,
R. M. Nakamura, and N. C. Pedersen.
1989.
Epidemiologic and clinical aspects of feline immunodeficiency virus infection in cats from the continental United States and Canada and possible mode of transmission.
J. Am. Vet. Med. Assoc.
194:213-220[Medline].
|
Journal of Clinical Microbiology, September 2000, p. 3448-3449, Vol. 38, No. 9
0095-1137/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.